{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:42:17Z","timestamp":1793497337982,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.seminoncol.2025.152391","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T17:40:33Z","timestamp":1752946833000},"page":"152391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prostate cancer in T\u00fcrkiye: Trend analysis of incidence and mortality rates"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-3440","authenticated-orcid":false,"given":"Guven","family":"Turan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Basbinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Ellidokuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.seminoncol.2025.152391_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0002","unstructured":"International Agency for Research on Cancer. Global Cancer observatory: cancer tomorrow. Available at: https:\/\/gco.iarc.fr\/tomorrow\/en\/dataviz\/isotype?cancers=27&single_unit=50000&years=2040&types=0&sexes=1 (Accessed 4 March 2024 )."},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152391_bib0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0004","series-title":"Cancer epidemiology and prevention","first-page":"1128","article-title":"Prostate cancer","author":"Platz","year":"2006"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0005","series-title":"Cancer epidemiology and prevention","first-page":"1128","article-title":"Prostate cancer","author":"Zhou","year":"2006"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152391_bib0006","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.euf.2018.02.007","volume":"5","author":"Brookman-May","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0007","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory: cancer Today. Available at: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/tables?mode=population&types=1&cancers=27&populations=991_992_993_994_995_996&multiple_populations=1 (Accessed 4 March 2024)."},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152391_bib0008","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152391_bib0009","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.eururo.2016.05.043","article-title":"Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries","volume":"70","author":"Wong","year":"2016","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152391_bib0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/M16-2586","article-title":"Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials","volume":"167","author":"Tsodikov","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152391_bib0011","first-page":"175","article-title":"Quantifying the role of PSA screening in the US prostate cancer mortality decline","volume":"19","author":"Etzioni","year":"2008","journal-title":"Can Caus Contr"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0012","unstructured":"International Agency for Research on Cancer. Population fact sheets: turkey.Available at: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/792-turkiye-fact-sheet.pdf (Accessed 4 March 2024)."},{"key":"10.1016\/j.seminoncol.2025.152391_bib0013","unstructured":"Republic of T\u00fcrkiye Ministry of Health, General Directorate of Public Health, Department of Cancer. Cancer Statistics. Available at: https:\/\/hsgm.saglik.gov.tr\/tr\/kanser-istatistikleri.html (Accessed 4 March 2024)."},{"key":"10.1016\/j.seminoncol.2025.152391_bib0014","unstructured":"Turkish Statistical Institute (TURKSTAT). Population and demography.Available at: https:\/\/data.tuik.gov.tr\/Kategori\/GetKategori?p=nufus-ve-demografi-109&dil=1 (Accessed 4 March 2024)."},{"key":"10.1016\/j.seminoncol.2025.152391_bib0015","unstructured":"Republic of T\u00fcrkiye Ministry of Health. Circular on Death Notification System (DNS) 2012\/05. Available at: https:\/\/dosyasb.saglik.gov.tr\/Eklenti\/35821,obs\u2013genelgepdf.pdf?0 (Accessed 4 March 2024)."},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152391_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152391_bib0017","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","article-title":"The role of increasing detection in the rising incidence of prostate cancer","volume":"273","author":"Potosky","year":"1995","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152391_bib0018","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1001\/jama.2015.14905","article-title":"Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations","volume":"314","author":"Jemal","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152391_bib0019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152391_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/ijc.29894","article-title":"Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group","volume":"138","author":"Zhou","year":"2016","journal-title":"Int J Cancer"},{"issue":"17","key":"10.1016\/j.seminoncol.2025.152391_bib0021","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.ejca.2010.09.013","article-title":"Prostate cancer incidence and mortality trends in 37 European countries: an overview","volume":"46","author":"Bray","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0022","article-title":"25-year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis","volume":"384","author":"Shelton","year":"2024","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152391_bib0023","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2188\/jea.JE20200416","article-title":"Updated trends in cancer in Japan: incidence in 1985-2015 and mortality in 1958-2018\u2014A sign of decrease in cancer incidence","volume":"31","author":"Katanoda","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.puhe.2019.04.016","article-title":"Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China","volume":"172","author":"Liu","year":"2019","journal-title":"Public Health"},{"issue":"24","key":"10.1016\/j.seminoncol.2025.152391_bib0025","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/djm249","article-title":"Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries","volume":"99","author":"Kv\u00e5le","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152391_bib0026","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1055-9965.EPI-14-0281","article-title":"Cancer in Africa 2012","volume":"23","author":"Parkin","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152391_bib0027","first-page":"1183","article-title":"World Cancer Research Fund International: continuous Update Project\u2014Systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk","volume":"30","author":"Chan","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0028","series-title":"Health statistics yearbook 2019","article-title":"General Directorate of Health Information Systems","year":"2021"},{"key":"10.1016\/j.seminoncol.2025.152391_bib0029","unstructured":"Republic of T\u00fcrkiye Ministry of Health, Public Health Institution of T\u00fcrkiye, Ankara, T\u00fcrkiye. Recommended periodic Health examinations and screening tests in Family medicine practice. Available at: https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/kronik-hastaliklar-ve-yasli-sagligi-db\/Dokumanlar\/Kitaplar\/Periyodik_Muayene_Rehberi.pdf (Accessed 4 March 2024)."},{"key":"10.1016\/j.seminoncol.2025.152391_bib0030","unstructured":"Acar S, Kazanc\u0131k LB, Meydan MC, I\u015f\u0131k M Socio-Economic Development Ranking of Provinces and Regions: SEGE-2017. Ankara: general directorate of development agencies, Republic of T\u00fcrkiye Ministry of Industry and Technology; 2019. Available at: https:\/\/www.sanayi.gov.tr\/merkez-birimi\/b94224510b7b\/sege\/il-sege-raporlari. (Accessed 26 May 2025)."},{"key":"10.1016\/j.seminoncol.2025.152391_bib0031","unstructured":"Ministry of Health of Turkey, Refik Saydam Hygiene Center Presidency, School of Public Health. Health statistics yearbook 2009. Ankara: Ministry of Health of Turkey; 2011. Available at: https:\/\/dosyasb.saglik.gov.tr\/Eklenti\/5101\/0\/siy2009pdf.pdf?_tag1=28C58B6DD52E79A05D188554EF73208852E89AC0. (Accessed 29 April 2025)."},{"key":"10.1016\/j.seminoncol.2025.152391_bib0032","unstructured":"Republic of T\u00fcrkiye Ministry of Health, General Directorate of Public Health, Department of Cancer. Turkey Cancer Control Program. Available at: https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/kanser-db\/Dokumanlar\/Raporlar\/Turkey_NCCP_18_April_2022.pdf (Accessed 4 March 2024)."},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152391_bib0033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.15511\/tahd.18.00128","article-title":"Evaluation of the patients who apply to family medicine policlinic","volume":"22","author":"Tekp\u0131nar","year":"2018","journal-title":"T\u00fcrkiye Aile Hekimli\u011fi Dergisi"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152391_bib0034","first-page":"90","article-title":"Awareness of cancer screening tests in Trabzon","volume":"1","author":"Bay\u00e7elebi","year":"2015","journal-title":"J Human Rhyth"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152391_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.24938\/kutfd.383092","article-title":"Knowledge levels of male patients about prostate cancer screening","volume":"20","author":"Ceyhan","year":"2018","journal-title":"K\u0131r\u0131kkale \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152391_bib0036","first-page":"387","article-title":"Why do men refuse prostate cancer screening? Demographic analysis in Turkey","volume":"9","author":"Ceber","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152391_bib0037","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/fampra\/cmt045","article-title":"Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing","volume":"30","author":"Hamoen","year":"2013","journal-title":"Fam Pract"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152391_bib0038","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jnci\/91.12.1025","article-title":"Cancer surveillance series: interpreting trends in prostate cancer\u2014Part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality","volume":"91","author":"Feuer","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152391_bib0039","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/ijms19051359","article-title":"Recent advances in prostate cancer treatment and drug discovery","volume":"19","author":"Nevedomskaya","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.seminoncol.2025.152391_bib0040","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152391_bib0041","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/jnci\/djt281","article-title":"The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource","volume":"105","author":"Zhu","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152391_bib0042","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bju.14580","article-title":"Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, colorectal and ovarian randomized cancer screening trial","volume":"123","author":"Pinsky","year":"2019","journal-title":"BJU Int"},{"issue":"9959","key":"10.1016\/j.seminoncol.2025.152391_bib0043","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"ERSPC Investigators. Screening and prostate cancer mortality: results of the European Randomised Study of screening for prostate cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152391_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"ERSPC investigators. A 16-year follow-up of the European Randomized Study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152391_bib0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2018.0154","article-title":"CAP Trial Group. Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial","volume":"319","author":"Martin","year":"2018","journal-title":"JAMA"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T17:45:47Z","timestamp":1752947147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0093775425000831"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152391","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer in T\u00fcrkiye: Trend analysis of incidence and mortality rates","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152391"}}